Degradation of the Retinoblastoma Tumor Suppressor by the Human Papillomavirus Type 16 E7 Oncoprotein Is Important for Functional Inactivation and Is Separable from Proteasomal Degradation of E7

ABSTRACT The steady-state level and metabolic half-life of retinoblastoma tumor suppressor protein pRB are decreased in cells that express high-risk human papillomavirus (HPV) E7 proteins. Here we show that pRB degradation is a direct activity of E7 and does not reflect a property of cell lines acquired during the selection process for E7 expression. An amino-terminal domain of E7 that does not directly contribute to pRB binding but is required for transformation is also necessary for E7-mediated pRB degradation. Treatment with inhibitors of the 26S proteasome not only blocks E7-mediated pRB degradation but also causes the stabilization of E7. Mutagenic analyses, however, reveal that the processes of proteasomal degradation of E7 and pRB are not linked processes. HPV type 16 E7 also targets the pRB-related proteins p107 and p130 for destabilization by a proteasome-dependent mechanism. Using the SAOS2 flat-cell assay as a biological indicator for pRB function, we demonstrate that pRB degradation, not solely binding, is important for the E7-induced inactivation of pRB.

[1]  A. Ciechanover,et al.  Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue , 2000, Oncogene.

[2]  N. Dyson,et al.  Requirements for cell cycle arrest by p16INK4a. , 2000, Molecular cell.

[3]  F. Dick,et al.  Mutagenesis of the pRB Pocket Reveals that Cell Cycle Arrest Functions Are Separable from Binding to Viral Oncoproteins , 2000, Molecular and Cellular Biology.

[4]  T. Littlewood,et al.  Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts , 2000, Oncogene.

[5]  B. Clurman,et al.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. , 2000, Molecular cell.

[6]  Katsuhiko Itoh,et al.  Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas , 2000, Nature Medicine.

[7]  J. T. Thomas,et al.  Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Münger,et al.  Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state , 1998, Oncogene.

[9]  X. Graña,et al.  Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth , 1998, Oncogene.

[10]  J. Decaprio,et al.  The J Domain of Simian Virus 40 Large T Antigen Is Required To Functionally Inactivate RB Family Proteins , 1998, Molecular and Cellular Biology.

[11]  W. Sellers,et al.  Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. , 1998, Genes & development.

[12]  Pipas Jm.  Molecular chaperone function of the SV40 large T antigen. , 1998 .

[13]  J. Pipas.  Molecular chaperone function of the SV40 large T antigen. , 1998, Developments in biological standardization.

[14]  K. Münger,et al.  Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. , 1997, Virology.

[15]  P. Raychaudhuri,et al.  Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  J. Decaprio,et al.  The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function , 1997, Journal of virology.

[17]  S. Bagchi,et al.  The Human Papillomavirus E7 Oncoprotein Functionally Interacts with the S4 Subunit of the 26 S Proteasome* , 1997, The Journal of Biological Chemistry.

[18]  G. Mills,et al.  Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition , 1997, Oncogene.

[19]  J. Decaprio,et al.  Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen , 1997, Molecular and cellular biology.

[20]  K. Münger,et al.  The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. , 1997, Genes & development.

[21]  C. Georgopoulos,et al.  The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Seamus J. Martin,et al.  Degradation of Retinoblastoma Protein in Tumor Necrosis Factor- and CD95-induced Cell Death* , 1997, The Journal of Biological Chemistry.

[23]  K. Münger,et al.  Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein , 1997, Journal of virology.

[24]  F. Kaye,et al.  Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding , 1997, Oncogene.

[25]  A. Porter,et al.  Specific cleavage of the retinoblastoma protein by an ICE‐like protease in apoptosis. , 1996, The EMBO journal.

[26]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[27]  Q. Dou,et al.  Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. , 1996, Cancer research.

[28]  H. zur Hausen,et al.  Papillomavirus infections--a major cause of human cancers. , 1996, Biochimica et biophysica acta.

[29]  K. Münger,et al.  A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. , 1994, Virology.

[30]  T. Iftner,et al.  Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1 , 1994, Journal of virology.

[31]  F. Carlotti,et al.  Functional studies of E7 proteins from different HPV types. , 1994, Oncogene.

[32]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[33]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[34]  T. Crook,et al.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation , 1993, Journal of virology.

[35]  Kathleen R. Cho,et al.  Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Münger,et al.  Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins , 1992, Journal of virology.

[37]  R. Weinberg,et al.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[38]  N. Dyson,et al.  Adenovirus E1A makes two distinct contacts with the retinoblastoma protein , 1992, Journal of virology.

[39]  J. Nevins,et al.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Münger,et al.  Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Münger,et al.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein , 1992, Journal of virology.

[42]  D. McCance,et al.  Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes , 1992, Journal of virology.

[43]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[44]  K. Vousden,et al.  Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. , 1990, Oncogene.

[45]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[46]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[47]  W. Lee,et al.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Münger,et al.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.

[49]  K. Vousden,et al.  A point mutational analysis of human papillomavirus type 16 E7 protein , 1989, Journal of virology.

[50]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[51]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[52]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[53]  Stephen H. Friend,et al.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.

[54]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[55]  F. Wettstein,et al.  The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein , 1987, Journal of virology.